Uluru Inc. (fka ULUR)

[wesley_]

volume surge on Novartis agreement - ULURU announces the Appointment of Novartis Animal Health as the Exclusive Distributor of a Veterinary Version of Altrazeal®

ADDISON, Texas, Sept. 8 ULURU Inc. (NYSE : ULU) announced today that it has signed a worldwide distribution agreement appointing Novartis the exclusive distributor of a veterinary version of Altrazeal® for marketing to the animal health sector.

Under the terms of the agreement ULURU will supply Novartis with finished product for marketing in the global markets. The agreement includes other wound care products that may be developed by ULURU that the parties mutually agree to be covered by this agreement.

Commenting on the agreement, Kerry P. Gray, President and CEO of ULURU, stated, "We are very pleased to be working with Novartis, a leading global animal health care company and one of the top 5 pharmaceutical companies in the world.

---